Atlas Trials

Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate

Clinical trial NCT02284880 · COMPLETED

Trial details

NCT number
NCT02284880
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-10-01
Primary completion
2010-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.